Sessions

Session 45

Thursday, September 3
2:00 – 4:00 pm

Room: Poulenc     

Achalasia update

     
Chairs: Valter N. Felix (Brasil) –  Michael F. Vaezi (USA)

Discussant: Uday C. Ghoshal (India)

• Achalasia subtypes—what do they mean?
  Sudep Gonlachanvit (Thailand)
• What is the likely etiology of achalasia—viral, autoimmune or something else?
  Uday C. Ghoshal (India)
• What is the usefulness of achalasia scores?
• Drugs for Achalasia: How and When?  
  Carmelo Scarpignato (Italy)
• Who should have PD and in whom surgery is the better option?
  Roberto Penagini (Italy)
• Pneumatic dilation of cardia. How to enhance best results? Charlotte Scheerens (Belgium)
• Botulinum toxin into LES. What is state of art? 
  Michael F. Vaezi (USA)
• POEM: update and comparison to myotomy.
  Jan Martinek (Czech Republic)
• How to avoid and how to treat esophageal perforations due to POEM?
  Jürgen Hochberger (Germany-France)
• Per-oral endoscopic re-myotomy as salvage procedure for recurrent dysphagia after Heller myotomy. Erwin Rieder (Austria)
• Dysphagia post PD/myotomy—is it recurrence or GERD? Eduardo De Moura (Brazil)
• Esophagectomy for end-stage achalasia. Is there a place for it yet? When and how?
  Valter N. Felix (Brazil)
• Should I do surveillance for cancer in achalasia? Luigi Bonavina (Italy)